dexlansoprazolum 30 mg, sacchari sphaerae 28.8 mg, magnesii carbonas, saccharum 41.5 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, hypromellosum, talcum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, acidi methacrylici copolymerum A, acidi methacrylici copolymerum B, macrogolum 8000, polysorbatum 80, silica colloidalis anhydrica, triethylis citras, E 171, Kapselhülle: carrageenanum, kalii chloridum, E 132 et E 133, E 171, E 172 (nigrum), aqua purificata, hypromellosum, E 172 (rubrum), E 172 (flavum), E 133, cera carnauba, lacca, glyceroli mono-oleas, pro capsula.
Packungsbestandteile
Kapseln mit veränderter Wirkstofffreisetzung
Active Agent
Dose
Dexlansoprazolum
30 mg
Inactive agents
Dose
additional_information
(Flavum)
(Nigrum)
(Rubrum)
Acidi Methacrylici
Acidi Methacrylici Copolymerum A
Acidi Methacrylici Copolymerum B
Aqua Purificata
Carrageenanum
Kapselhülle
Cera Carnauba
E 132
color.
E 133
color.
E 171
color.
E 172
color.
Ethylis Acrylatis Polymerisatum Dispersio
30
Glyceroli Mono-Oleas
Hydroxypropylcellulosum
Hydroxypropylcellulosum Substitutum Humile
Hypromellosum
Potassium Chloride
Lacca
Macrogol
8000
Magnesii Carbonas
Per Centum
Polysorbatum 80
Pro Capsula
Sacchari Sphaerae
28.8 mg
Saccharum
41.5 mg
Silica Colloidalis Anhydrica
Talcum
Triethylis Citras
Source
Data was imported : 14.04.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
